Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care.
Industry sector: Medical
Sector classification: Medical laboratories
Deep Learning based analysis and prediction model for Quest Diagnostics Incorporated (DGX) stock is a 2nd Generation Non-linear Autoregressive (NAR) model based on the LSTM/GRU Recurrent Neural Network architecture.
Model is in the production pipeline since Oct. 22, 2015.
Market data for DGX model training are being downloaded from the Quandl premium datasets on a daily basis.
Model is being retrained on a regular basis.
|% Held by Insiders||1.79%|
|% Held by Institutions||88.84%|
|EPS (last reported FY)||$5.40|
|EPS (last reported Q)||$1.52|
|EPS, estimated (last reported Q)||$1.52|
|Total revenues||$8 B|
|Net income||$1 B|